‘A great improvement’: ECS delivers fourth consecutive cash flow positive quarter by Adam Sheldon July 20, 2026July 20, 2026 ECS Botanics has described FY2026 as a year of “great improvement” after delivering a fourth consecutive […]
ECS Botanics: German GMP guidance could have ‘global impact’ by Adam Sheldon July 8, 2026July 8, 2026
Austranna says high-tech facility could ‘double’ Australia’s growing capacity by Adam Sheldon June 16, 2026June 18, 2026
‘We could become a formidable force’: Cannaponics launches public capital raise by Adam Sheldon May 13, 2026May 14, 2026
Ora Pharm buys key Helius Therapeutics assets in major NZ deal by Adam Sheldon May 13, 2026May 13, 2026
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
TGA issues quality warning and prepares to begin testing after reports of ‘questionable’ products by Steve Jones April 19, 2024April 23, 2024
